Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMNVFZA)

Drug Name
AC-1202 Drug Info
Synonyms Ketasyn
Indication
Disease Entry ICD 11 Status REF
Memory loss MB21.1Z Phase 2 [1]
Cross-matching ID
PubChem CID
10850
ChEBI ID
CHEBI:76978
CAS Number
CAS 538-23-8
TTD Drug ID
DMNVFZA

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ketogenesis (KG) TTNHYJL NOUNIPROTAC Modulator [2]

References

1 ClinicalTrials.gov (NCT00142805) Ketasyn in Mild to Moderate Alzheimer's Disease. U.S. National Institutes of Health.
2 Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009 Aug 10;6:31.